MedTrace Logo

Generation of an Induced Pluripotent Stem (iPS) Cell Bank Immune Matched to a Majority of the US Population

NCT03434808 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2020-07-15

No results posted yet for this study

Summary

The purpose of this study is to develop a collection of iPS cells called a bank ("Bank") that are immune-matched to a large percentage of the US population by containing the most common HLA haplotypes in the US population.

Conditions

  • iPS Cell Manufacture and Banking

Interventions

OTHER

Whole Blood Donation

Study subjects will provide 250ml whole blood donation for the manufacture and banking of iPS cells.

Sponsors & Collaborators

Principal Investigators

  • Dennis Confer, MD · National Marrow Donor Program

  • Amanda Mack, PhD · Cellular Dynamics International, Inc. - A FUJIFILM Company

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
61 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-13
Primary Completion
2018-08-17
Completion
2018-08-17

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03434808 on ClinicalTrials.gov